<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/118</identifier>
				<datestamp>2024-10-30T18:54:16Z</datestamp>
				<setSpec>aavptbiennial:SI</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Panel on Statistical Aspects of Clinical Trials: Moderator Remarks</dc:title>
	<dc:creator xml:lang="en">Powers, Jean D.</dc:creator>
	<dc:description xml:lang="en">This morning, we have representatives of the regulatory agency, a representative from industry and also two of my colleagues from academia that are going to give you an overview of how we view the statistics of clinical trials.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1982-04-13</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/118</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Third Symposium; 36</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/118/112</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1982 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
